467 related articles for article (PubMed ID: 35582583)
1. Dodging the bullet: therapeutic resistance mechanisms in pediatric cancers.
Shah N
Cancer Drug Resist; 2019; 2(3):428-446. PubMed ID: 35582583
[TBL] [Abstract][Full Text] [Related]
2. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
3. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic nanoparticles to combat cancer drug resistance.
Hu CM; Zhang L
Curr Drug Metab; 2009 Oct; 10(8):836-41. PubMed ID: 20214578
[TBL] [Abstract][Full Text] [Related]
5. p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance.
Souza LCME; Faletti A; Veríssimo CP; Stelling MP; Borges HL
Membranes (Basel); 2022 Feb; 12(2):. PubMed ID: 35207121
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of tumor cell resistance to the current targeted-therapy agents.
Khamisipour G; Jadidi-Niaragh F; Jahromi AS; Zandi K; Hojjat-Farsangi M
Tumour Biol; 2016 Aug; 37(8):10021-39. PubMed ID: 27155851
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies to overcome taxane resistance in cancer.
Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
[TBL] [Abstract][Full Text] [Related]
8. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles in Chemoresistance.
De Rubis G; Bebawy M
Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
[TBL] [Abstract][Full Text] [Related]
10. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeted therapy: novel therapeutic approach for head and neck cancer.
Shrivastava S; Nagi R; Sharma S; Rasul Sanadi SA; Dafallah ET; Ragit A
Ther Deliv; 2020 Oct; 11(10):637-651. PubMed ID: 32777985
[TBL] [Abstract][Full Text] [Related]
12. Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks.
Petanidis S; Kioseoglou E; Salifoglou A
Curr Med Chem; 2019; 26(4):607-623. PubMed ID: 29149832
[TBL] [Abstract][Full Text] [Related]
13. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
14. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
Rossig C; Juergens H; Berdel WE
Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
[TBL] [Abstract][Full Text] [Related]
15. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.
Chen Z; Li Y; Tan B; Zhao Q; Fan L; Li F; Zhao X
Drugs Today (Barc); 2020 Jul; 56(7):469-482. PubMed ID: 32648857
[TBL] [Abstract][Full Text] [Related]
16. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.
Senthebane DA; Rowe A; Thomford NE; Shipanga H; Munro D; Mazeedi MAMA; Almazyadi HAM; Kallmeyer K; Dandara C; Pepper MS; Parker MI; Dzobo K
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754000
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Min HY; Lee HY
Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
[TBL] [Abstract][Full Text] [Related]
18. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
Gaggianesi M; Di Franco S; Pantina VD; Porcelli G; D'Accardo C; Verona F; Veschi V; Colarossi L; Faldetta N; Pistone G; Bongiorno MR; Todaro M; Stassi G
Front Oncol; 2021; 11():702642. PubMed ID: 34354950
[TBL] [Abstract][Full Text] [Related]
19. Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework.
Avner BS; Fialho AM; Chakrabarty AM
Bioengineered; 2012; 3(5):262-70. PubMed ID: 22750915
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
